« Return to News | Awards & Advancement

Unigene appoints Mayes and Pepper to biotechnologies SBU

Friday, February 10, 2012 11:48 AM

Unigene Laboratories announced the expansion of its biotechnologies strategic business unit (SBU) with the promotion of Gregory T. Mayes to chief business officer and appointment of Jane Pepper to senior director, business development.

Gregory T. Mayes, Esq. previously held the Unigene position of vice president of corporate development and general counsel, the latter which he will retain with his appointment to chief business officer. Mayes has been an integral part of the turnaround management team that spearheaded Unigene's successful rescue in 2011.  He also has been instrumental securing an impressive eight new therapeutic peptide oral drug delivery feasibility studies during the second half of last year.

Jane Pepper, M.B.A, Ph.D., previously was in the development organization of Novartis Pharmaceuticals. She will be responsible for further leveraging Unigene's Peptelligence platform for the oral drug delivery of therapeutic peptides across a broad spectrum of disease areas by continuing to build a robust portfolio of strategically partnered opportunities.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.